AAAAAA
Results:
1-21
|
Results: 21
Authors:
Evans, ND
Godfrey, KR
Chapman, MJ
Chappell, MJ
Aarons, L
Duffull, SB
Citation: Nd. Evans et al., An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine, J PHARMA PH, 28(1), 2001, pp. 93-105
Authors:
Aarons, L
Karlsson, MO
Mentre, F
Rombout, F
Steimer, JL
van Peer, A
Citation: L. Aarons et al., Role of modelling and simulation in Phase I drug development, EUR J PH SC, 13(2), 2001, pp. 115-122
Authors:
Nestorov, I
Graham, G
Duffull, S
Aarons, L
Fuseau, E
Coates, P
Citation: I. Nestorov et al., Modeling and simulation for clinical trial design involving a categorical response: A phase II case study with naratriptan, PHARM RES, 18(8), 2001, pp. 1210-1219
Authors:
Duffull, SB
Mentre, F
Aarons, L
Citation: Sb. Duffull et al., Optimal design of a population pharmacodynamic experiment for ivabradine, PHARM RES, 18(1), 2001, pp. 83-89
Authors:
Aarons, L
Graham, G
Citation: L. Aarons et G. Graham, Methodological approaches to the population analysis of toxicity data, TOX LETT, 120(1-3), 2001, pp. 405-410
Authors:
Simpson, JA
Aarons, L
White, NJ
Citation: Ja. Simpson et al., How can we do pharmacokinetic studies in the tropics?, T RS TROP M, 95(4), 2001, pp. 347-351
Authors:
Deleu, D
Aarons, L
Ahmed, IA
Citation: D. Deleu et al., Population pharmacokinetics of free carbamazepine in adult Omani epilepticpatients, EUR J CL PH, 57(3), 2001, pp. 243-248
Authors:
Aarons, L
Citation: L. Aarons, Art theft: An exploratory study of the illegitimate art market in Australia, AUST NZ J C, 34(1), 2001, pp. 17-37
Authors:
Ingwersen, SH
Pedersen, PC
Groes, L
Nielsen, KK
Aarons, L
Citation: Sh. Ingwersen et al., Population pharmacokinetics of tiagabine in epileptic patients on monotherapy, EUR J PH SC, 11(3), 2000, pp. 247-254
Authors:
Duffull, SB
Aarons, L
Citation: Sb. Duffull et L. Aarons, Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers, EUR J PH SC, 10(4), 2000, pp. 275-284
Authors:
Duffull, SB
Chabaud, S
Nony, P
Laveille, C
Girard, P
Aarons, L
Citation: Sb. Duffull et al., A pharmacokinetic simulation model for ivabradine in healthy volunteers, EUR J PH SC, 10(4), 2000, pp. 285-294
Authors:
Simpson, JA
Watkins, ER
Price, RN
Aarons, L
Kyle, DE
White, NJ
Citation: Ja. Simpson et al., Mefloquine pharmacokinetic-pharmacodynamic models: Implications for dosingand resistance, ANTIM AG CH, 44(12), 2000, pp. 3414-3424
Authors:
Herrick, AL
Grennan, DM
Aarons, L
Citation: Al. Herrick et al., Lack of interaction between methotrexate and penicillins, RHEUMATOLOG, 38(3), 1999, pp. 284-285
Authors:
Aarons, L
Citation: L. Aarons, Pharmacokinetic and pharmacodynamic modelling in drug development, STAT ME M R, 8(3), 1999, pp. 181-182
Authors:
Evans, L
Aarons, L
Coates, P
Citation: L. Evans et al., A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patients, PHARM RES, 16(10), 1999, pp. 1608-1615
Authors:
Aarons, L
Citation: L. Aarons, Software for population pharmacokinetics and pharmacodynamics, CLIN PHARMA, 36(4), 1999, pp. 255-264
Authors:
Niopas, I
Toon, S
Aarons, L
Rowland, M
Citation: I. Niopas et al., The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans, EUR J CL PH, 55(5), 1999, pp. 399-404
Authors:
Simpson, JA
Price, R
ter Kuile, F
Teja-Isavatharm, P
Nosten, F
Chongsuphajaisiddhi, T
Looareesuwan, S
Aarons, L
White, NJ
Citation: Ja. Simpson et al., Population pharmacokinetics of mefloquine in patients with acute falciparum malaria, CLIN PHARM, 66(5), 1999, pp. 472-484
Authors:
Gupta, SK
Sathyan, G
Lindemulder, EA
Ho, PL
Sheiner, LB
Aarons, L
Citation: Sk. Gupta et al., Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships, CLIN PHARM, 65(6), 1999, pp. 672-684
Authors:
Nestorov, I
Aarons, L
Rowland, M
Citation: I. Nestorov et al., Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity, J PHAR BIOP, 26(5), 1998, pp. 521-545
Authors:
Chou, CH
Aarons, L
Rowland, M
Citation: Ch. Chou et al., Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination, J PHAR BIOP, 26(5), 1998, pp. 595-615
Risultati:
1-21
|